MannKind



Ebitda Lave om Dato
Adma Biologics USD 40.41M 1.17M 2024-12
Dynavax Technologies USD 439K 11.7M 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Halozyme Therapeutics USD 195.96M 12.4M 2024-12
Insmed USD -241795000 46.45M 2024-12
MacroGenics USD 56.03M 112.4M 2024-09
MannKind USD 26.22M 8.59M 2024-12
Merck USD 7.12B 1.06B 2024-12
Novo Nordisk DKK 35.97B 233M 2024-09
Pfizer USD 4.71B 3.04B 2024-12
Sanofi EUR 4.25B 2.22B 2024-09
Xencor USD 7.14M 64.97M 2024-12



MannKind - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.